Transmarket Holdings »

Apellis Pharmaceuticals shares owned by Transmarket Holdings

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Transmarket Holdings from 13F filings

Historical chart of Transmarket Holdings investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Transmarket Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Transmarket Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $949k 24k 40.23

More positions owned by Transmarket Holdings

Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
GSK Sponsored Adr (GSK)
Ishares Tr 3 7 Yr Treas Bd (IEI)
BP Sponsored Adr (BP)
Novartis Sponsored Adr (NVS)
Aegon Amer Reg 1 Cert (AEG)
Prudential Adr (PUK)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Sealed Air
Vodafone Group Sponsored Adr (VOD)
Diageo Spon Adr New (DEO)
Amicus Therapeutics (FOLD)
Spdr Series Trust State Street Spd (JNK)

View all positions for Transmarket Holdings

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals